577 related articles for article (PubMed ID: 21873689)
1. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects.
Terao C; Ohmura K; Kochi Y; Ikari K; Maruya E; Katayama M; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
Ann Rheum Dis; 2011 Dec; 70(12):2134-9. PubMed ID: 21873689
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
[TBL] [Abstract][Full Text] [Related]
3. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
[TBL] [Abstract][Full Text] [Related]
4. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
[TBL] [Abstract][Full Text] [Related]
5. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
[TBL] [Abstract][Full Text] [Related]
6. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
[TBL] [Abstract][Full Text] [Related]
7. Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis.
Usnayo MJ; Andrade LE; Alarcon RT; Oliveira JC; Silva GM; Bendet I; Burlingame R; Porto LC; Pinheiro Gda R
Rev Bras Reumatol; 2011; 51(5):474-83. PubMed ID: 21952999
[TBL] [Abstract][Full Text] [Related]
8. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
9. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
10. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
11. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
12. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
13. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
Bang SY; Lee HS; Lee KW; Bae SC
J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
Verpoort KN; van Gaalen FA; van der Helm-van Mil AH; Schreuder GM; Breedveld FC; Huizinga TW; de Vries RR; Toes RE
Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
van Heemst J; Hensvold AH; Jiang X; van Steenbergen H; Klareskog L; Huizinga TW; van der Helm-van Mil A; Catrina AI; Toes RE; Lundberg K; van der Woude D
Ann Rheum Dis; 2016 Oct; 75(10):1891-8. PubMed ID: 26715653
[TBL] [Abstract][Full Text] [Related]
16. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population.
Mariaselvam CM; Fortier C; Charron D; Krishnamoorthy R; Tamouza R; Negi VS
HLA; 2016 Nov; 88(5):253-258. PubMed ID: 27753285
[TBL] [Abstract][Full Text] [Related]
17. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
[TBL] [Abstract][Full Text] [Related]
18. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility.
López-Arbesu R; Ballina-García FJ; Alperi-López M; López-Soto A; Rodríguez-Rodero S; Martínez-Borra J; López-Vázquez A; Fernández-Morera JL; Riestra-Noriega JL; Queiro-Silva R; Quiñones-Lombraña A; López-Larrea C; González S
Rheumatology (Oxford); 2007 Mar; 46(3):426-30. PubMed ID: 17003176
[TBL] [Abstract][Full Text] [Related]
19. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study.
Bengtsson C; Padyukov L; Källberg H; Saevarsdottir S
Ann Rheum Dis; 2014 Jun; 73(6):1096-100. PubMed ID: 23613482
[TBL] [Abstract][Full Text] [Related]
20. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences.
Kochi Y; Yamada R; Kobayashi K; Takahashi A; Suzuki A; Sekine A; Mabuchi A; Akiyama F; Tsunoda T; Nakamura Y; Yamamoto K
Arthritis Rheum; 2004 Jan; 50(1):63-71. PubMed ID: 14730600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
